Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Medtronic
NYSE:MDT Community
3
Narratives
written by author
4
Comments
on narratives written by author
236
Fair Values set
on narratives written by author
Create a narrative
Medtronic
Popular
Undervalued
Overvalued
Medtronic
EV
Evangelos
Community Contributor
Medtronic Stock: A Compelling Buy for Value and Income Investors as Robotics, Innovation Catalysts Ignite Upside to $105+
Strengths and Competitive Advantages: Diverse Product Portfolio: Medtronic operates across four key segments—Cardiovascular, Medical-Surgical, Neuroscience, and Diabetes—providing revenue stability and reducing dependency on any single product line. This diversification surpasses more specialized competitors like Boston Scientific (focused on cardiovascular) or Intuitive Surgical (robotics).
View narrative
US$95.00
FV
7.4% undervalued
intrinsic discount
5.15%
Revenue growth p.a.
Set as Fair Value
8
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
4 days ago
author updated this narrative
Medtronic
NA
NateF
Community Contributor
MDT Market Outlook
Medtronic plc (NYSE: MDT) is a leading medical device company with a diverse product portfolio and a strong global presence. As of January 4, 2025, the stock is trading at approximately $80.95 per share.
View narrative
US$82.66
FV
6.4% overvalued
intrinsic discount
4.58%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
about 2 months ago
author updated this narrative
Medtronic
WA
Analyst Price Target
Consensus Narrative from 26 Analysts
I Anticipate That Advancements In Robotics And Diabetes Technology Will Strengthen Future Market Position
Key Takeaways Strong innovation in high-impact markets and disciplined cost management are driving consistent earnings and revenue growth. Strategic investments and technological advancements in segments like robotics and diabetes are expected to enhance competitive advantage and future growth.
View narrative
US$94.96
FV
7.4% undervalued
intrinsic discount
4.65%
Revenue growth p.a.
Set as Fair Value
1
users have liked this narrative
0
users have commented on this narrative
34
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
MDT
Medtronic
Your Fair Value
US$
Current Price
US$87.94
0.1% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
42b
2015
2018
2021
2024
2025
2027
2030
Revenue US$41.6b
Earnings US$5.3b
Advanced
Set as Fair Value